Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 405

1.

Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.

Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AY, Holm S, Gustavsson B, Benesch M, Müller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jiménez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U.

Neuro Oncol. 2017 May 11. doi: 10.1093/neuonc/nox056. [Epub ahead of print]

PMID:
28499018
2.

Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.

Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J.

BMJ Open. 2017 May 9;7(5):e013739. doi: 10.1136/bmjopen-2016-013739.

3.

Posterior cranial fossa tumours in children at National Cancer Institute, Sudan: a single institution experience.

Elhassan MMA, Osman HHM, Parkes J.

Childs Nerv Syst. 2017 Apr 21. doi: 10.1007/s00381-017-3414-1. [Epub ahead of print]

PMID:
28432426
4.

Does the Good Schools Toolkit Reduce Physical, Sexual and Emotional Violence, and Injuries, in Girls and Boys equally? A Cluster-Randomised Controlled Trial.

Devries KM, Knight L, Allen E, Parkes J, Kyegombe N, Naker D.

Prev Sci. 2017 Apr 10. doi: 10.1007/s11121-017-0775-3. [Epub ahead of print]

PMID:
28397155
5.

How did the Good School Toolkit reduce the risk of past week physical violence from teachers to students? Qualitative findings on pathways of change in schools in Luwero, Uganda.

Kyegombe N, Namakula S, Mulindwa J, Lwanyaaga J, Naker D, Namy S, Nakuti J, Parkes J, Knight L, Walakira E, Devries KM.

Soc Sci Med. 2017 May;180:10-19. doi: 10.1016/j.socscimed.2017.03.008. Epub 2017 Mar 7.

6.

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

Tanwar S, Trembling PM, Hogan BJ, Srivastava A, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM.

Eur J Gastroenterol Hepatol. 2017 Mar;29(3):289-296. doi: 10.1097/MEG.0000000000000789.

PMID:
27906753
7.

Outcomes of children with rhabdomyosarcoma treated with intensive chemotherapy, surgery, and radiotherapy through a period of protocol revision at a South African center, 1990-2010.

Hendricks M, Parkes J, Pillay K, Millar A, van Eyssen A, Numanoglu A, Davidson A.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26248. Epub 2016 Sep 22.

PMID:
27654324
8.

Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies.

Parkes JE, Rothwell S, Day PJ, McHugh NJ, Betteridge ZE, Cooper RG, Ollier WE, Chinoy H, Lamb JA; Myositis Genetics Consortium (MYOGEN)..

Arthritis Res Ther. 2016 Jul 7;18(1):156. doi: 10.1186/s13075-016-1061-7.

9.

Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C: A Comparison of 10 Biomarkers Using 2 Different Assays for Hyaluronic Acid.

Tanwar S, Trembling PM, Hogan BJ, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM.

J Clin Gastroenterol. 2017 Mar;51(3):268-277. doi: 10.1097/MCG.0000000000000581.

PMID:
27380461
10.

Coffee, caffeine and non-alcoholic fatty liver disease?

Kennedy OJ, Roderick P, Poole R, Parkes J.

Therap Adv Gastroenterol. 2016 May;9(3):417-8. doi: 10.1177/1756283X16636765. Epub 2016 Mar 11. No abstract available.

11.

Type 2 diabetes and risk of hospital admission or death for chronic liver diseases.

Wild SH, Morling JR, McAllister DA, Kerssens J, Fischbacher C, Parkes J, Roderick PJ, Sattar N, Byrne CD; Scottish and Southampton Diabetes and Liver Disease Group.; Scottish Diabetes Research Network Epidemiology Group..

J Hepatol. 2016 Jun;64(6):1358-64. doi: 10.1016/j.jhep.2016.01.014. Epub 2016 Jan 23.

PMID:
26812073
12.

Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis.

Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J.

Aliment Pharmacol Ther. 2016 Mar;43(5):562-74. doi: 10.1111/apt.13523. Epub 2016 Jan 25. Review.

PMID:
26806124
13.

Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.

Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W.

AIDS. 2016 Mar 13;30(5):723-9. doi: 10.1097/QAD.0000000000000975.

14.

Introducing students to clinical audit.

Parkes J, O'Dell C.

Nurs Manag (Harrow). 2015 Nov;22(7):22-6. doi: 10.7748/nm.22.7.22.s26.

PMID:
26508069
15.

Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol.

Klonoff DC, Lias C, Beck S, Parkes JL, Kovatchev B, Vigersky RA, Arreaza-Rubin G, Burk RD, Kowalski A, Little R, Nichols J, Petersen M, Rawlings K, Sacks DB, Sampson E, Scott S, Seley JJ, Slingerland R, Vesper HW.

J Diabetes Sci Technol. 2016 May 3;10(3):697-707. doi: 10.1177/1932296815614587. Print 2016 May.

16.

The role of microRNAs in the idiopathic inflammatory myopathies.

Parkes JE, Day PJ, Chinoy H, Lamb JA.

Curr Opin Rheumatol. 2015 Nov;27(6):608-15. doi: 10.1097/BOR.0000000000000225. Review.

PMID:
26398013
17.

A clinical in-market evaluation of an alginate fibre dressing.

Parkes J.

Br J Nurs. 2015 Aug 13-Sep 19;24(15):S28, S30-5. doi: 10.12968/bjon.2015.24.Sup15.S28.

PMID:
26266561
18.

Evaluation of recruitment and selection for specialty training in public health: interim results of a prospective cohort study to measure the predictive validity of the selection process.

Pashayan N, Gray S, Duff C, Parkes J, Williams D, Patterson F, Koczwara A, Fisher G, Mason BW.

J Public Health (Oxf). 2016 Jun;38(2):e194-200. doi: 10.1093/pubmed/fdv102. Epub 2015 Aug 11.

PMID:
26265476
19.

Accuracy Evaluation of CONTOUR(®)PLUS Compared With Four Blood Glucose Monitoring Systems.

Dunne N, Viggiani MT, Pardo S, Robinson C, Parkes JL.

Diabetes Ther. 2015 Sep;6(3):377-88. doi: 10.1007/s13300-015-0121-3. Epub 2015 Jul 14.

20.

An evaluation of a Singing for the Brain pilot with people with a learning disability and memory problems or a dementia.

Ward AR, Parkes J.

Dementia (London). 2017 Apr;16(3):360-374. doi: 10.1177/1471301215592539. Epub 2016 Jul 27.

PMID:
26160277

Supplemental Content

Loading ...
Support Center